References 243Kobayashi, J. S. (1997). The evolution of adjustment issues in
HIV/AIDS.Bulletin of the Menninger Clinic, 61,146...188.
Koblin, B. A., Heagerty, P., Sheon, A., Buchbinder, S., Celum, C.,
Douglas, J. M., et al. (1998). Readiness of high-risk populations
in the HIV Network for Prevention Trials to participate in HIV
vaccine ef“cacy trials in the United States. AIDS, 12,785...793.
Larder, B. A., & Kemp, S. D. (1989). Multiple mutations in HIV-1
reverse transcriptase confer high-level resistance to zidovudine
(AZT).Science, 246,1155...1158.
Last, J. M. (1995). A dictionary of epidemiology(3rd ed.). New
York: Oxford University.
Latkin, C. A. (1998). Outreach in natural settings: The use of peer
leaders for HIV prevention among injecting drug users• net-
works.Public Health Reports, 113(Suppl. 1), 151...159.
Laws, M. B., Wilson, I. B., Bowser, D. M., & Kerr, S. E. (2000).
Taking antiretroviral therapies for HIV infection: Learning from
patient•s stories. Journal of General Internal Medicine, 15,
848...858.
Leserman, J., Jackson, E. D., Petitto, J. M., Golden, R. N., Silva, S. G.,
Perkins, D. O., et al. (1999). Progression to AIDS: The effects of
stress, depressive symptoms, and social support.Psychosomatic
Medicine, 61,397...406.
Low-Beer, S., Chan, K., Yip, B., Wood, E., Montaner, J. S.,
O•Shaughnessy, M. V., et al. (2000). Depressive symptoms
decline among persons on HIV protease inhibitors. Journal of
Acquired Immune Deficiency Syndromes, 23,295...301.
Lui, K. J., Darrow, W. W., & Rutherford, G. W. D. (1988). A model-
based estimate of the mean incubation period for AIDS in homo-
sexual men. Science, 240,1333...1335.
Malow, R. M., Baker, S. M., Klimas, N., Antoni, M. H., Schneider-
man, N., Penedo, F. J., et al. (1998). Adherence to complex com-
bination antiretroviral therapies by HIV-positive drug abusers.
Psychiatric Services, 49,1021...1024.
Mayer, K. H. (1999). Combination antiretroviral chemotherapy:
Shifting paradigms and evolving praxis. In D. G. Ostrow & S. C.
Kalichman (Eds.),Psychosocial and public health impacts of new
HIV therapies(pp. 1...26).New York: Kluwer Academic/Plenum
Press.
McKinlay, J. B. (1995). The new public health approach to improv-
ing physical activity and autonomy in older populations. In
E. Heikkinen, J. Kuusinen, & I. Ruoppila (Eds.), Preparation for
aging(pp. 87...103).New York: Plenum Press.
Metzger, D. S., Navaline, H., & Woody, G. E. (1998). Drug abuse
treatment as AIDS prevention. Public Health Reports,
113 (Suppl. 1), 97...106.
Metzler, C. W., Biglan, A., Noell, J., Ary, D. V., & Ochs, L. (2000).
A randomized controlled trial of a behavioral intervention to
reduce high-risk sexual behavior among adolescents in STD
clinics.Behavior Therapy, 31,27...54.
Montaner, J. S., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway,
B., et al. (1998). A randomized, double-blind trial comparing
combinations of nevirapine, didanosine, and zidovudine for
HIV-infected patients. Journal of the American Medical Associ-
ation, 279,930...937.
Moss, A. R., & Bacchetti, P. (1989). Natural history of HIV infec-
tion.AIDS, 3,55...61.
Mostashari, F., Riley, E., Selwyn, P. A., & Altice, F. L. (1998). Ac-
ceptance and adherence with antiretroviral therapy among HIV-
infected women in a correctional facility. Journal of Acquired
Immune Deficiency Syndromes and Human Retrovirology, 18,
341...348.
National Institute of Mental Health. (1998). The NIMH Multisite
HIV Prevention Trial: Reducing HIV sexual risk behavior.
Science, 280,1889...1894.
Needle, R. H., Coyle, S. L., Normand, J., Lambert, E., & Cesari, H.
(1998). HIV prevention with drug-using populations: Current
status and future prospects: Introduction and overview. Public
Health Reports, 113(Suppl. 1), 4...15.
Nelson, K. E., Celentano, D. D., Eiumtrakol, S., Hoover, D. R.,
Beyrer, C., Suprasert, S., et al. (1996). Changes in sexual behav-
ior and a decline in HIV infection among young men in
Thailand.New England Journal of Medicine, 335,297...303.
Ostrow, D. G., Joseph, J. G., Kessler, R., Soucy, J., Tal, M., Eller, M.,
et al. (1989). Disclosure of HIV antibody status: Behavioral and
mental health correlates.AIDS Education and Prevention, 1,1...11.
Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O.,
Fuhrer, J., Satten, G. A., et al. (1998). Declining morbidity and
mortality among patients with advanced human immunode“-
ciency virus infection: HIV Outpatient Study investigators. New
England Journal of Medicine, 338,853...860.
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N.,
Squier, C., et al. (2000). Adherence to protease inhibitor therapy
and outcomes in patients with HIV infection. Annals of Internal
Medicine, 133,21...30.
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In
search of how people change: Applications to addictive behav-
iors.American Psychologist, 47,1102...1114.
Rabkin, J. G., & Chesney, M. (1999). Treatment adherence to HIV
medications: The achilles heel of the new therapies. In D. G.
Ostrow & S. C. Kalichman (Eds.), Psychosocial and public
health impacts of new HIV therapies(pp. 61...79). New York:
Kluwer Academic/Plenum.
Rabkin, J. G., & Ferrando, S. J. (1997). A • second lifeŽ agenda: Psy-
chiatric research issues raised by protease inhibitor treatments
for people with the human immunode“ciency virus or the ac-
quired immunode“ciency syndrome. Archives of General Psy-
chiatry, 54,1049...1053.
Rabkin, J. G., Ferrando, S. J., Lin, S. H., Sewell, M., & McElhiney,
M. (2000). Psychological effects of HAART: A 2-year study.
Psychosomatic Medicine, 62,413...422.
Rabkin, J. G., Goetz, R. R., Remien, R. H., Williams, J. B., Todak,
G., & Gorman, J. M. (1997). Stability of mood despite HIV ill-
ness progression in a group of homosexual men. American Jour-
nal of Psychiatry, 154,231...238.